Results for tag: "Wegener Granulomatosis"

Wegener Granulomatosis (WG) is a rare autoimmune disorder that affects the blood vessels and organs. It is classified as a type of vasculitis, which is an inflammation of the blood vessels. Symptoms of WG include inflammation of the nose and sinuses, lung inflammation, kidney inflammation, and joint pain. Treatment for WG typically involves a combination of medications, such as corticosteroids, immunosuppressants, and biologic agents. The Wegener Granulomatosis market within the context of Allergy and Immunology is a niche market, with a limited number of products available. The market is largely driven by the need for effective treatments for WG, as well as the increasing prevalence of the disorder. The market is expected to grow in the coming years, as new treatments are developed and the number of patients diagnosed with WG increases. Some companies in the Wegener Granulomatosis market include GlaxoSmithKline, Pfizer, Novartis, and AbbVie. Show Less Read more